RemSleep Holdings Inc (RMSL)

[James salmon]

Not sure what you are smoking but PR today clearly states this;

“Uplisting to the OTCQB® will assist our company in providing greater shareholder value by allowing us to achieve greater market visibility, expand our potential prospective investor pool, greater share price stability, along with increased trading liquidity within the investment community. We look forward to broadening our company exposure to a larger and more diverse demographic of both domestic and international investors,” stated Tom Wood, RemSleep CEO. Wood continued “Uplisting to OTCQB® is the one of several exciting developments we have on the horizon. We are confident in obtaining FDA approval for our patented DeltaWave CPAP nasal interface, and our subsequent upcoming 510k FDA application for our 2nd CPAP mask. We also have our recent CPAP machine distribution deal that is progressing well, and are currently transitioning from a pre-revenue company to a positive cash flow and profitable company. I could not be more excited for what we have in store for our investors and the entire CPAP industry as a whole. We believe that are positioning RemSleep to be a disruptive force within the CPAP industry for years to come.”